REGISTERED NUMBER: 09324612 (England and Wales)

Financial Statements for the Year Ended 31 October 2025

for

Portland Clinical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Mr K D Heppenstall

Mr I A Yuill

REGISTERED OFFICE:

28 Bailey Street

Sheffield

South Yorkshire

S1 4EH

REGISTERED NUMBER:

09324612 (England and Wales)

SENIOR STATUTORY AUDITOR:

James Salim FCCA

AUDITORS:

SMH Group Audit

Statutory Auditors

5 Westbrook Court

Sharrow Vale Road

Sheffield

South Yorkshire

S11 8YZ

FIXED ASSETS

Tangible assets

4

25,921

29,668

CURRENT ASSETS

Debtors

5

2,403,373

2,425,290

Cash at bank

16,233

164,098

2,419,606

2,589,388

CREDITORS

Amounts falling due within one year

6

1,257,960

1,001,706

NET CURRENT ASSETS

1,161,646

1,587,682

TOTAL ASSETS LESS CURRENT LIABILITIES

1,187,567

1,617,350

PROVISIONS FOR LIABILITIES

6,175

7,045

NET ASSETS

1,181,392

1,610,305

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

1,181,292

1,610,205

SHAREHOLDERS' FUNDS

1,181,392

1,610,305

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2026 and were signed on its behalf by:

Mr K D Heppenstall - Director

1.	STATUTORY INFORMATION

Portland Clinical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on cost

Taxation

Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2024 - 9 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 November 2024

46,164

Additions

8,279

At 31 October 2025

54,443

DEPRECIATION

At 1 November 2024

16,496

Charge for year

12,026

At 31 October 2025

28,522

NET BOOK VALUE

At 31 October 2025

25,921

At 31 October 2024

29,668

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

1,158,828

850,497

Amounts owed by group undertakings

75,652

-

Other debtors

1,168,893

1,574,793

2,403,373

2,425,290

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

48,468

19,068

Amounts owed to group undertakings

-

57,515

Taxation and social security

402,175

387,571

Other creditors

807,317

537,552

1,257,960

1,001,706

Included within other creditors is an amount of £651,841 (2024: £366,720) relating to invoice discounting advances, these advances are secured by way of first fixed and floating charges over the present and future assets of the company.

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

88

Ordinary A

£1

88

88

12

Ordinary B

£1

12

12

100

100

8.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

James Salim FCCA (Senior Statutory Auditor)

for and on behalf of SMH Group Audit

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2025 and 31 October 2024:

2025

2024

£

£

Mr I A Yuill

Balance outstanding at start of year

-

-

Amounts advanced

162,555

-

Amounts repaid

-

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

162,555

-

10.	RELATED PARTY DISCLOSURES

At the year end, £673,000 (2024: £1,402,485) was owed from companies under the common control of Mr M J Davison.

11.	ULTIMATE CONTROLLING PARTY

The controlling party is Mr M J Davison.

At 31 October 2025 the company's parent company was Portland Clinical Holdings Limited, a company which is incorporated in the UK, which is the parent of both the smallest and largest group in which the results of the company are published. The accounts of this company are available to the public and may be obtained from Companies House, Cardiff.